Literature DB >> 25169539

TP53 polymorphisms in sporadic North Indian breast cancer patients.

Sarika Sharma1, Vasudha Sambyal, Kamlesh Guleria, Mridu Manjari, Meena Sudan, Manjit Singh Uppal, Neeti Rajan Singh, Darpan Bansal, Arun Gupta.   

Abstract

BACKGROUND: The purpose of this study was to evaluate the potential association of five (p.P47S, p.R72P, PIN3 Ins16bp, p.R213R and r.13494g>a) polymorphisms of TP53 with the risk of developing breast cancer in North Indian Punjabi population.
METHODS: We screened DNA samples of 200 sporadic breast cancer patients (197 females and 3 males) and 200 unrelated healthy, gender and age matched individuals for the polymorphisms.
RESULTS: For the p.P47S polymorphism, we observed the PP genotype in 99.5% of the patients and PS genotype in only 1 patient. All the controls had the wild type PP genotype. The frequency of RR, RP and PP genotype of p.R72P was 23.5% vs 33.5%, 51.5% vs 45.5% and 25% vs 21% in patients and controls respectively. Heterozygous (RP) genotype was increased in breast cancer patients as compared to controls (51.5 vs 45.5%) and showed 1.61 fold significantly increased risk for breast cancer (OR=1.61, 95% CI, 1.01-2.58, p=0.04). In breast cancer patients the frequencies of A1A1, A1A2 and A2A2 genotypes of PIN3 Ins16bp polymorphism were 67%, 26% and 7% respectively whereas in controls the genotype frequencies were 68.5%, 27.5% and 4% respectively, with no significant difference. For p.R213R (c.639A>G), all individuals had homozygous wild type genotype. The frequencies of GG, GA and AA genotypes of TP53 r.13494g>a polymorphism were 62 vs 67.5%, 33 vs 28% and 5 vs 4.5% in patients and controls respectively, again without significant difference. We observed that RP- A1A1 genotype combination of p.R72P and PIN3 Ins16bp and RP-GG combination of p.R72P and r.13494g>a polymorphism showed significant risk of breast cancer (OR=1.65, 95%CI: 0.98-2.78, p=0.05; OR=1.72, 95%CI: 1.01-2.92, p=0.04).
CONCLUSION: The results of present study indicated that among the five TP53 polymorphisms investigated, the p.R72P polymorphism, and the RP-A1A1 and RP-GG genotype combination contribute to breast cancer susceptibility in North Indians.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25169539     DOI: 10.7314/apjcp.2014.15.16.6871

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  6 in total

1.  Association of PIN3 16-bp duplication polymorphism of TP53 with breast cancer risk in Mali and a meta-analysis.

Authors:  Brehima Diakite; Yaya Kassogue; Guimogo Dolo; Oumar Kassogue; Mamadou Lassine Keita; Brian Joyce; Erin Neuschler; Jun Wang; Jonah Musa; Cheick Bougari Traore; Bakarou Kamate; Etienne Dembele; Sellama Nadifi; Mercy Isichei; Jane L Holl; Robert Murphy; Seydou Doumbia; Lifang Hou; Mamoudou Maiga
Journal:  BMC Med Genet       Date:  2020-07-03       Impact factor: 2.103

2.  p.Arg72Pro polymorphism of P53 and breast cancer risk: a meta-analysis of case-control studies.

Authors:  Brehima Diakite; Yaya Kassogue; Guimogo Dolo; Jun Wang; Erin Neuschler; Oumar Kassogue; Mamadou L Keita; Cheick B Traore; Bakarou Kamate; Etienne Dembele; Sellama Nadifi; Robert L Murphy; Seydou Doumbia; Lifang Hou; Mamoudou Maiga
Journal:  BMC Med Genet       Date:  2020-10-19       Impact factor: 2.103

3.  Association of TP53 Codon 72 Arg>Pro Polymorphism with Breast and Lung Cancer Risk in the South Asian Population: A Meta-Analysis.

Authors:  Sarah Jafrin; Md Abdul Aziz; Shamima Nasrin Anonna; Tahmina Akter; Nura Ershad Naznin; Sharif Reza; Mohammad Safiqul Islam
Journal:  Asian Pac J Cancer Prev       Date:  2020-06-01

4.  Determination of expression profile of p53 gene in different grades of breast cancer tissues by real time PCR.

Authors:  Haleema Sadia; Munir Ahmad Bhinder; Asma Irshad; Beenish Zahid; Rais Ahmed; Sana Ashiq; Kausar Malik; Muhammad Riaz; Tariq Nadeem; Kanwal Ashiq; Ali Akbar
Journal:  Afr Health Sci       Date:  2020-09       Impact factor: 0.927

5.  Impact on breast cancer susceptibility and clinicopathological traits of common genetic polymorphisms in TP53, MDM2 and ATM genes in Sardinian women.

Authors:  Matteo Floris; Giovanna Pira; Paolo Castiglia; Maria Laura Idda; Maristella Steri; Maria Rosaria De Miglio; Andrea Piana; Andrea Cossu; Antonio Azara; Caterina Arru; Giovanna Deiana; Carlo Putzu; Valeria Sanna; Ciriaco Carru; Antonello Serra; Marco Bisail; Maria Rosaria Muroni
Journal:  Oncol Lett       Date:  2022-08-08       Impact factor: 3.111

6.  No association of TP53 codon 72 and intron 3 16-bp duplication polymorphisms with breast cancer risk in Chinese Han women: new evidence from a population-based case-control investigation.

Authors:  Weiming Hao; Xia Xu; Haifeng Shi; Chiyu Zhang; Xiaoxiang Chen
Journal:  Eur J Med Res       Date:  2018-10-11       Impact factor: 2.175

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.